Cardiovascular Business -- Women in primary prevention implantable cardioverter-defibrillator (ICD) trials have the same overall mortality as men, while experiencing significantly less appropriate ICD interventions, according to a meta-analysis of five randomized studies published in this month’s HeartRhythm Journal.
